People · Operator
Named in public records as an officer, director or promoter · active 2019–2025 · Pharmaceuticals, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Osteal Therapeutics, Inc. | — | Pharmaceuticals | Series C | $127.5M | $87.1M | 2020 |
| BrightSpec, Inc. | — | Other Technology | Series A | $17.1M | $15.5M | 2019 |
David Cash at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Cash on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Thompson | 1 | 10 |
| Thomas Jones | 1 | 10 |
| Renee Ryan | 1 | 6 |
| Jenny Rooke | 1 | 5 |
| Douglas Kohrs | 1 | 4 |
| Dan Kidle | 1 | 4 |
| Robert Creeden | 1 | 4 |
| George Kastendike | 1 | 4 |
| Rushu Luo | 1 | 3 |
| Martin Sands | 1 | 2 |
| ROBERT LLOYD | 1 | 2 |
| JAFFRAY WOODRIFF | 1 | 2 |
| Biren Mehta | 1 | 2 |
| Noam Krantz | 1 | 2 |
| Jude Paganelli | 1 | 2 |
| Sonal Patel | 1 | 1 |
| Terry Dunlay | 1 | 1 |
| DAVID MCDANIEL | 1 | 1 |
| Judson Cooper | 1 | 1 |
| Timothy Germann | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.